Kamada Ltd. | Income Statement

Fiscal year is January-December. All values ILS Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
254,914.30
254,213.30
271,600.10
297,481.30
369,858.90
411,546.20
Cost of Goods Sold (COGS) incl. D&A
161,200.60
202,032.80
212,257.30
217,915.20
258,104.50
265,477.80
Gross Income
93,713.70
52,180.50
59,342.80
79,566.10
111,754.40
146,068.40
SG&A Expense
80,358.50
93,243.10
103,727.60
100,088.10
84,978.50
75,709.10
EBIT
13,355.20
41,062.60
44,384.70
20,522.00
26,775.90
70,359.30
Unusual Expense
-
-
-
518.20
-
-
Non Operating Income/Expense
1,523.20
-
2,428.30
487.50
2,201.40
1,046.20
Interest Expense
11,189.50
11,779.70
3,628.80
483.70
582.70
1,222.40
Pretax Income
1,685.60
47,079.50
43,786.40
19,236.10
25,790.30
73,131.20
Income Tax
86.60
186.00
-
6,610.40
967.60
7,028.70
Consolidated Net Income
1,599.00
47,265.50
43,786.40
25,846.40
24,822.70
80,160
Net Income
1,599.00
47,265.50
43,786.40
25,846.40
24,822.70
80,160
Net Income After Extraordinaries
1,599.00
47,265.50
43,786.40
25,846.40
24,822.70
80,160
Net Income Available to Common
1,599.00
47,265.50
43,786.40
25,846.40
24,822.70
80,160
EPS (Basic)
0.04
1.32
1.20
0.69
0.65
1.99
Basic Shares Outstanding
32,714.60
35,971.30
36,245.80
36,418.80
37,970.70
40,275.40
EPS (Diluted)
0.05
1.31
1.21
0.71
0.65
1.98
Diluted Shares Outstanding
33,385.70
35,971.30
36,245.80
36,418.80
38,045.10
40,445.40
EBITDA
24,187.30
31,089.40
31,847.10
7,600.80
39,448.00
83,672.60
Non-Operating Interest Income
1,043.10
5,762.90
1,798.90
1,800.40
1,798.50
2,948.10

About Kamada

View Profile
Address
Science Park
Rehovot TA 7670402
Israel
Employees -
Website http://www.kamada.com
Updated 07/08/2019
Kamada Ltd. engages in the development and production of pharmaceutical products. It operates through the following business segments: Proprietary Products, and Distribution. The Proprietary Products segment develops, manufactures and sells plasma-derived protein therapeutics products.